Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    ZEISS Revenue Increases by 11% to $7 Billion

    Article obtained from Photonics RSS Feed.

    The ZEISS Group saw revenue grow by 11% in fiscal year 2018-2019, reaching €6.43 billion ($7.18 billion USD; previous year: €5.82 billion). Zeiss’ fiscal year 2018-2019 ended Sept. 30, 2019. Adjusted for currency and acquisition effects, revenue rose by 8%. ZEISS’ earnings before interest and taxes (EBIT) exceeded €1 billion for the first time, with €1.06 billion at an EBIT margin of 17%. Incoming orders increased by 9%, reaching €6.58 billion..

    In fiscal year 2018-2019, the ZEISS Group saw growth in all four of its market segments. The Semiconductor Manufacturing Technology segment grew 7% to €1.63 billion and achieved record revenue in part due to the market launch of extreme ultraviolet…

    READ MORE
    Dec, 23 2019 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.